Repeated administration of frusemide does not offer an advantage over single dosing in attenuating exercise-induced pulmonary hypertension in thoroughbred horses.

The research study examines if giving a second dose of frusemide is more beneficial than a single dose in reducing exercise-induced pulmonary hypertension in Thoroughbred horses.

Methodology

• The study was conducted on seven healthy, exercise-trained Thoroughbred horses.
• These horses were put through exercises at a speed of 14.2 m/s on a 3.5% uphill grade. The idea was to make them perform at their maximum heart rate, which was around 217 beats per minute.
• The horses were randomly subjected to three conditions or treatments, spaced seven days apart. The conditions were control (no medication), single dose frusemide (250 mg given intravenously 4 hours before exercise), and double dose frusemide (two 250 mg doses, one given 4 hours before exercise, and the next given 2 hours before exercise).

Findings

• When no medication was given (control condition), exercise resulted in significant right atrial and pulmonary hypertension in the horses.
• In the single dose frusemide experiment, a notable reduction of the exercise-induced rise in right atrial and pulmonary vascular pressures was observed.
• Interestingly, the double dose frusemide experiment did not show significant changes in the exercise-induced right atrial and pulmonary hypertension, in comparison to the single dose experiment.

Conclusion

• From the above observations, the researchers concluded that giving an extra dose of frusemide is unlikely to be more effective in reducing exercise-induced pulmonary hypertension in racing Thoroughbred horses than administering a single dose.